Skip to main content

Advertisement

SpringerLink
Log in

Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Background

Some laboratory and clinical features are associated with a probability of recurrence after transnasal adenomectomy for Cushing disease (CD). However, there is no consensus on a set of predictors. Rules for prediction of recurrence were not proposed earlier.

Aim

To develop prediction model of recurrence/remission after successful neurosurgical treatment for CD.

Methods

Retrospective single-site comparative study included 349 patients (52 men and 297 women) with a verified diagnosis of CD who underwent effective endoscopic transsphenoidal adenomectomy between 2007 and 2014. Clinical and laboratory parameters were evaluated. Laboratory tests were performed using immunochemiluminescent method. Time-to-event analysis and ROC-analysis were applied. Multivariate models were developed using logistic regression and artificial neural network (ANN).

Results

Postoperative cortisol and ACTH levels and their combinations cannot be used for prediction of recurrence. ANN for prediction of recurrence within 3 years after successful surgery was developed. Input variables are age, duration of the disease, MRI data on adenoma, morning postoperative levels of ACTH and cortisol, output variable is binary (recurrence/remission). Predictive value for remission is 93%, 95% CI [89%; 96%], and predictive value for recurrence is 85%, 95% CI [71%; 94%]. Web-calculator based on the model is developed and free for use.

Conclusion

Effective method for prediction of recurrence and long-term remission within 3 years after successful endoscopic transsphenoidal adenomectomy is proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Notes

  1. Data on 4 of 223 cases became available after the multivariate analysis was performed.

References

  1. Biller B, Grossman A, Stewart P et al (2008) Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. Clin Endocrinol Metab 93:2454–2462. https://doi.org/10.1210/jc.2007-2734

    Article  CAS  Google Scholar 

  2. Nieman L, Biller B, Findling J et al (2015) Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807–2831. https://doi.org/10.1210/jc.2015-1818

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bochicchio D, Losa M, Buchfelder M (1995) Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 80:3114–3120. https://doi.org/10.1210/jcem.80.11.7593411

    Article  CAS  PubMed  Google Scholar 

  4. Hameed N, Yedinak CG, Brzana J et al (2013) Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Pituitary 16:452–458. https://doi.org/10.1007/s11102-012-0455-z

    Article  CAS  PubMed  Google Scholar 

  5. McCance D, Gordon D, Fannin T et al (1993) Assessment of endocrine function after transsphenoidal surgery for Cushing’s disease. Clin Endocrinol (Oxf) 38:79–86. https://doi.org/10.1111/j.1365-2265.1993.tb00976.x

    Article  CAS  Google Scholar 

  6. van Aken M, de Herder W, van der Lely A et al (1997) Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing’s disease. Clin Endocrinol (Oxf) 47:145–149. https://doi.org/10.1046/j.1365-2265.1997.2541051.x

    Article  Google Scholar 

  7. Shimon I, Ram Z, Cohen Z et al (2002) Transsphenoidal surgery for Cushing’s disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51(1):57–61. https://doi.org/10.1210/er.2013-1048

    Article  CAS  PubMed  Google Scholar 

  8. Alexandraki K, Kaltsas G, Isidori A et al (2013) Long-term remission and recurrence rates in Cushing’s disease: predictive factors in a single-centre study. Eur J Endocrinol 168:639–648. https://doi.org/10.1530/EJE-12-0921

    Article  CAS  PubMed  Google Scholar 

  9. Aranda G, Enseñat J, Mora M et al (2015) Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up. Pituitary 18:142–149. https://doi.org/10.1007/s11102-014-0567-8

    Article  CAS  PubMed  Google Scholar 

  10. Barbetta L, Dall’Asta C, Tomei G et al (2001) Assessment of cure and recurrence after pituitary surgery for Cushing’s disease. Acta Neurochir (Wien) 143:477–482. https://doi.org/10.1007/S007010170077

    Article  CAS  Google Scholar 

  11. Petersenn S, Beckers A, Ferone D et al (2015) Therapy of endocrine disease: outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur J Endocrinol 172(6):227–239. https://doi.org/10.1530/EJE-14-0883

    Article  CAS  Google Scholar 

  12. Lonser R, Nieman L, Oldfield E (2017) Cushing’s disease: pathobiology, diagnosis, and management. J Neurosurg 126(2):404–417. https://doi.org/10.3171/2016.1.JNS152119

    Article  PubMed  Google Scholar 

  13. Kim J, Shin C, Paek S et al (2012) Recurrence of Cushing’s disease after primary transsphenoidal surgery in a university hospital in Korea. Endocr J 59(10):881–888. https://doi.org/10.1507/endocrj.EJ12-0109

    Article  CAS  PubMed  Google Scholar 

  14. Dedov II, Melnichenko GA (eds) (2016) Russian clinical guidelines. Endocrinology, Moscow (in Russian)

    Google Scholar 

  15. Pettersen J, Halvorsen H, Evang J et al (2015) Low immediate postoperative serum-cortisol Nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing’s disease. BMC Endocr Disord 15:62. https://doi.org/10.1186/s12902-015-0055-9

    Article  CAS  Google Scholar 

  16. Marova E., Arapova S, Belaya Z et al (2012) Cushing’s disease: the clinical features, diagnostics, treatment. In: Dedov, II, Melnichenko GA (eds) Practical guide for doctors. Moscow, pp 2–32 (in Russian)

  17. Melnichenko G, Dedov I, Belaya Z et al (2015) Cushing’s disease: the clinical features, diagnostics, differential diagnostics, and methods of treatment. Probl Endocrinol 61(2):55–77. https://doi.org/10.14341/probl201561255-77 (in Russian)

    Article  Google Scholar 

  18. Roelfsema F, Biermasz N, Pereira A et al (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1):71–83. https://doi.org/10.1007/s11102-011-0347-7

    Article  PubMed  Google Scholar 

  19. Dickerman R, Oldfield E (2002) Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery. Neurosurgery 97(6):1343–1349. https://doi.org/10.3171/jns.2002.97.6.1343

    Article  Google Scholar 

  20. Oldfield E (2011) Surgical management of Cushing’s disease: a personal perspective. Clin Neurosurg 58:13–26. https://doi.org/10.1227/neu.0b013e3182269d3f

    Article  PubMed  Google Scholar 

  21. Wislocky G (1938) The vascular supply of the hypophysis cerebri of the Rhesus monkey and man. Proc Assoc Res Ment Dis 17:48–68

    Google Scholar 

  22. Burke W, Penn D, Repetti C et al (2019) Outcomes after repeat transsphenoidal surgery for recurrent Cushing disease: updated. Neurosurgery. https://doi.org/10.1093/neuros/nyz193

    Article  PubMed  Google Scholar 

  23. Jagannathan J, Smith R, DeVroom H (2009) Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J Neurosurg 111(3):531–539. https://doi.org/10.3171/2008.8.JNS08339

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dallapiazza R, Oldfield E, Jane J (2015) Surgical management of Cushing’s disease. Pituitary 18(2):211–216. https://doi.org/10.1007/s11102-015-0646-5

    Article  PubMed  Google Scholar 

  25. Reincke M, Sbiera S, Hayakawa A et al (2015) Mutations in the deubiquitinase gene USP8 cause Cushing’s disease. Nat Genet 47:31–38. https://doi.org/10.1038/ng.3166

    Article  CAS  PubMed  Google Scholar 

  26. Ma ZY, Song ZJ, Chen JH et al (2015) Recurrent gain-of-function USP8 mutations in Cushing’s disease. Cell Res 25(3):306–317

    Article  CAS  Google Scholar 

  27. Perez-Rivas L, Theodoropoulou M, Ferraù F et al (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing’s disease. J Clin Endocrinol Metab 100:E997–E1004. https://doi.org/10.1210/jc.2015-1453

    Article  PubMed  PubMed Central  Google Scholar 

  28. Albani A, Pérez-Rivas L, Dimopoulou C et al (2018) The USP8 mutational status may predict long-term remission in patients with Cushing’s disease. Clin Endocrinol. https://doi.org/10.1111/cen.13802

    Article  Google Scholar 

  29. Marova E, Kolesnikova G, Arapova S et al (2016) Factors predicting the outcomes of removal of corticotropinom in Cushing’s disease. Endocr Surg 10(4):20–30. https://doi.org/10.14341/serg2016420-30 (in Russian)

    Article  Google Scholar 

  30. Galiana P, Montañana C, Riesgo Suárez P et al (2013) Predictors of long-term remission after transsphenoidal surgery in Cushing’s disease. Endocrinol Nutr 60(8):475–482. https://doi.org/10.1016/j.endonu.2012.09.009

    Article  Google Scholar 

  31. Bansal P, Lila A, Goroshi M et al (2017) Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease. Endocr Connect 6(8):625–636. https://doi.org/10.1530/EC-17-0175

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Johnston P, Kennedy L, Hamrahian A et al (2017) Surgical outcomes in patients with Cushing’s disease: the Cleveland Clinic experience. Pituitary. https://doi.org/10.1007/s11102-017-0802-127

    Article  PubMed  Google Scholar 

  33. Lambert J, Goldberg L, Fayngold S et al (2013) Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients. J Clin Endocrinol Metab 98(3):1022–1030. https://doi.org/10.1210/jc.2012-2893

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank M.S. Antyukh for programming the web calculator.

Author information

Authors and Affiliations

  1. Endocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia

    Elena Y. Nadezhdina, Andrey Y. Grigoriev, Oksana V. Ivaschenko, Vilen N. Azizyan, Galina A. Melnichenko & Ivan I. Dedov

  2. National Research University Higher School of Economics, 20 Myasnitskaya Ul., 101000, Moscow, Russia

    Olga Yu. Rebrova

  3. Pirogov Russian National Research Medical University, 1 Ostrovitianov str., 117997, Moscow, Russia

    Olga Yu. Rebrova

Authors
  1. Elena Y. Nadezhdina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olga Yu. Rebrova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrey Y. Grigoriev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oksana V. Ivaschenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vilen N. Azizyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Galina A. Melnichenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ivan I. Dedov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Y. Nadezhdina.

Ethics declarations

Conflict of interest

All authors on this manuscript have declared that they have no conflict of interest.

Ethical approval

The study protocol was approved by the Local Ethical Committee of the Endocrinology Research Centre.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nadezhdina, E.Y., Rebrova, O.Y., Grigoriev, A.Y. et al. Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy. Pituitary 22, 574–580 (2019). https://doi.org/10.1007/s11102-019-00985-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-019-00985-5

Keywords

Search

Navigation